David Jérémie Birnbaum

Dr. David Jérémie Birnbaum


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2014 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
DBDavid Jérémie Birnbaum
David Jérémie Birnbaum
OTOlivier Turrini
Olivier Turrini
Luca ViganòLuca Viganò
Luca Viganò
NRNadia Russolillo
Nadia Russolillo
AAAurélie Autret
Aurélie Autret
JHJean Hardwigsen
Jean Hardwigsen

8 April 2019 in Cancers
Verified
Journal Article
Open access
PDF file
DBDavid Jérémie Birnbaum
David Jérémie Birnbaum
FBFrançois Bertucci
François Bertucci
PFPascal FINETTI
Pascal FINETTI
DBDaniel Birnbaum
Daniel Birnbaum
Emilie MamessierEmilie Mamessier
Emilie Mamessier
The association between pancreatic ductal adenocarcinoma (PDAC) location (head vs. Body/Tail (B/T)) and clinical outcome remains controversial. We collected clinicopathological and gene expression data from 249 resected PDAC samples from public data sets, and we compared data between 208 head and 41 B/T samples. The 2-year overall survival (OS) was better for the head than for the B/T PDACs (44 vs. 27%, p = 0.043), especially when comparing tumors with similar TNM classification (T3/4N0M0: 67% vs. 17%, p = 0.002) or from the same molecular class (squamous subtype: 31% vs. 0%, p < 0.0001). Bailey’s molecular subtypes were differentially distributed within the two groups, with the immunogenic subtype being underrepresented in the “B/T” group (p = 0.005). Uni- and multivariate analyses indicated that PDAC anatomic location was an independent prognostic factor. Finally, the supervised analysis identified 334 genes differentially expressed. Genes upregulated in the “head” group suggested lymphocyte activation and pancreas exocrine functions. Genes upregulated in the “B/T” group were related to keratinocyte differentiation, in line with the enrichment for squamous phenotype. We identified a robust gene expression signature (GES) associated with B/T PDAC location, suggesting that head and B/T PDAC are different. This GES could serve as an indicator for differential therapeutic management based on PDAC location.

1 November 2012 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
PDF file
DBDavid Jérémie Birnbaum
David Jérémie Birnbaum
JHJean Hardwigsen
Jean Hardwigsen
LBLouise Barbier
Louise Barbier
NBNizar Bouchiba
Nizar Bouchiba
YTYves Patrice Le Treut
Yves Patrice Le Treut

30 April 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
DBDavid Jérémie Birnbaum
David Jérémie Birnbaum
PFPascal FINETTI
Pascal FINETTI
DBDaniel Birnbaum
Daniel Birnbaum
Emilie MamessierEmilie Mamessier
Emilie Mamessier
FBFrançois Bertucci
François Bertucci
Pancreatic adenocarcinoma (PAC) is one of the most aggressive human cancers and new systemic therapies are urgently needed. Exportin-1 (XPO1), which is a member of the importin-β superfamily of karyopherins, is the major exporter of many tumor suppressor proteins that are involved in the progression of PAC. Promising pre-clinical data using XPO1 inhibitors have been reported in PAC, but very few data are available regarding XPO1 expression in clinical samples. Retrospectively, we analyzed XPO1 mRNA expression in 741 pancreatic samples, including 95 normal, 73 metastatic and 573 primary cancers samples, and searched for correlations with clinicopathological and molecular data, including overall survival. XPO1 expression was heterogeneous across the samples, higher in metastatic samples than in the primary tumors, and higher in primaries than in the normal samples. “XPO1-high” tumors were associated with positive pathological lymph node status and aggressive molecular subtypes. They were also associated with shorter overall survival in both uni- and multivariate analyses. Supervised analysis between the “XPO1-high” and “XPO1-low” tumors identified a robust 268-gene signature, whereby ontology analysis suggested increased XPO1 activity in the “XPO1-high” tumors. XPO1 expression refines the prognostication in PAC and higher expression exists in secondary versus primary tumors, which supports the development of XPO1 inhibitors in this so-lethal disease.

15 February 2012 in Cell Cycle
Verified
Journal Article
Closed access
PDF file
DBDavid Jérémie Birnbaum
David Jérémie Birnbaum
Emilie MamessierEmilie Mamessier
Emilie Mamessier
DBDaniel Birnbaum
Daniel Birnbaum
Pancreatic adenocarcinoma is one of the most aggressive human cancers. It displays many different chromosomal abnormalities and mutations. To design new therapeutic strategies, it is important to identify the signaling pathways and gene networks within this apparent complexity that are predominantly altered. The TGFβ signaling pathway and associated transcription network emerges as a central actor of pancreatic oncogenesis. Its tumor suppressor function in this tissue can be affected by several alterations.

1 January 2013 in Journal of Surgical Technique and Case Report
Verified
Journal Article
Open access
PDF file
DBDavid Jérémie Birnbaum
David Jérémie Birnbaum
YGYann Geffroy
Yann Geffroy
GGGéraldine Goin
Géraldine Goin
PBPaul Balandraud
Paul Balandraud
Midgut malrotation (MMR) is a congenital anomaly referring to either nonrotation or incomplete rotation of the primitive intestinal loop around the axis of the superior mesenteric artery during fetal development. Adult MMR is rare and majority of MMR in adults remains asymptomatic throughout life. The increasing use of diagnostic imaging for acute abdominal pain will lead to more incidental recognitions of MMR. Up to now, surgical treatment has been guided by the experience from pediatric surgery, and Ladd's procedure has been the treatment of choice in adults with MMR. However, a major dilemma arises when patients are essentially asymptomatic and incidentally diagnosed with MMR during another abdominal affection like acute appendicitis. The surgeon has to decide whether it is necessary to also treat the MMR. Here, we report a rare case of a 37-year-old patient with acute left side appendicitis in association with asymptomatic MMR. We discuss whether correction of the asymptomatic malrotation was indicated.